Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Date of authorisation: 26/05/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Evrysdi, risdiplam, Date of authorisation: 26/03/2021, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Trisenox, arsenic trioxide, Date of authorisation: 05/03/2002, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Lenvima, lenvatinib, Date of authorisation: 28/05/2015, Revision: 27, Status: Authorised

Quality of medicines questions and answers: Part 2

Use of Bayesian methods in clinical development - Scientific guideline

Concept paper for the development of a reflection paper on the use of Bayesian methods in clinical development

Human medicines European public assessment report (EPAR): Kisplyx, lenvatinib, Date of authorisation: 25/08/2016, Revision: 27, Status: Authorised

Concept paper on the revision of the guideline on clinical evaluation of diagnostic agents and its appendix 1 on imaging agents

Human medicines European public assessment report (EPAR): Pemetrexed Accord, pemetrexed, Date of authorisation: 18/01/2016, Revision: 15, Status: Authorised